- Home
- CBSH vs AXSM Comparison
CBSH vs AXSM Comparison
Compare CBSH & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CBSH | AXSM |
|---|---|---|
| Founded | 1865 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 5.9B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | CBSH | AXSM |
|---|---|---|
| Price | $52.86 | $153.85 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 20 |
| Target Price | $61.43 | ★ $176.00 |
| AVG Volume (30 Days) | ★ 1.1M | 471.7K |
| Earning Date | 01-21-2026 | 11-03-2025 |
| Dividend Yield | ★ 1.91% | N/A |
| EPS Growth | ★ 14.42 | N/A |
| EPS | ★ 3.99 | N/A |
| Revenue | ★ $1,684,917,000.00 | $561,263,000.00 |
| Revenue This Year | $10.14 | $66.20 |
| Revenue Next Year | $11.08 | $57.56 |
| P/E Ratio | $13.30 | ★ N/A |
| Revenue Growth | 4.25 | ★ 65.83 |
| 52 Week Low | $48.69 | $75.56 |
| 52 Week High | $65.59 | $152.94 |
Technical Indicators
Market Signals| Indicator | CBSH | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 46.28 | 63.49 |
| Support Level | $52.70 | $145.07 |
| Resistance Level | $53.64 | $149.13 |
| Average True Range (ATR) | 0.97 | 4.48 |
| MACD | 0.09 | -0.39 |
| Stochastic Oscillator | 55.28 | 91.02 |
Price Performance
Historical ComparisonAbout CBSH Commerce Bancshares Inc.
Commerce Bancshares Inc operates as the bank holding company for Commerce Bank. The bank is engaged in the general banking business, providing a broad range of retail, mortgage banking, corporate, investment, trust, and asset management products and services to individuals, businesses, and municipalities. It operates through three segments: Consumer, Commercial, and Wealth. The Commercial segment provides corporate lending, payment solutions, leasing, international services, and business banking. The Consumer segment covers retail banking, mortgages, installment lending, and card services. The Wealth segment offers trust and estate planning, brokerage, and investment management services.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.